Who We Are
Advancing Precision Medicine with Revolutionary Vesicle-Based Platforms
Aurexo Therapeutics is a biopharmaceutical company pioneering the discovery and development of next-generation targeted therapeutics through a revolutionary engineered platform derived from extracellular vesicles with inherent targeting capabilities. This novel process enables a safe, cost-effective, and scalable solution for advancing the delivery of precision medicine.
Aurexo Therapeutics has built a broad and diverse pipeline with multiple promising opportunities targeting a range of cancer types. Its proprietary technology is grounded in deep scientific expertise and strengthened by licensed innovations developed in collaboration with strategic partners. To further advance this platform, Aurexo Therapeutics continues focused research efforts to identify, develop, and validate new therapeutic candidates with the potential to address significant unmet medical needs.
Our Mission
Our mission is to develop breakthrough biologics that precisely target disease, spare healthy tissue, and deliver meaningful clinical impact for patients who need safer, more effective treatment options.
Our Vision
Our vision is to establish Aurexo Therapeutics as a global leader in novel engineered therapeutics—advancing a new class of biologics that redefine how cancer and complex diseases are treated while addressing critical unmet patient needs.
